pillbase.ru

CAMZYOS

Active substance: mavacamten

CAPSULE, GELATIN COATED · MAVACAMTEN 5 mg/1

United StatesActive

Marketing holder: Myokardia, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Camzyos
    Mavacamten
    EMEA/H/C/005457
    Bristol-Myers Squibb Pharma EEIG
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-d11a-783a-9322-2faee194ca77,01a12095-1db5-7bbb-9488-cd2f40a31a8d,01a12095-1db7-73a8-aa0d-1b9b9390633b,01a12095-1db8-7a8d-b1b4-b90105f27cc1;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
73625-112
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 73625-112 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 73625-112 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 73625-112 · Verified 2026-10-09 · open in source